An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of response.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Male or female adults ≥ 18 years of age.
• Diagnosis of chronic plaque-type psoriasis for at least 6 months
• Moderate to Severe plaque psoriasis as defined by BSA ≥10 PASI ≥12 IGA ≥3
• Able to give written informed consent prior to performance of any study related procedures
• Subject is able to attend Narrowband UVB phototherapy sessions three times a week and all other protocol specified visits
• Subject must be in general good health (except for psoriasis) as judged by the Investigator, based on medical history, physical examination.
Locations
United States
New Jersey
Elise Nelson
RECRUITING
East Windsor
Contact Information
Primary
Jerry Bagel, MD
dreamacres1@aol.com
6094434500
Backup
Elise Nelson
enelson@windsordermatology.com
6094434500
Time Frame
Start Date: 2017-11-07
Estimated Completion Date: 2020-01-01
Participants
Target number of participants: 30
Treatments
Experimental: Open Label Narrowband UVB phototherapy
Open Label Narrowband UVB phototherapy for 12 weeks.
Related Therapeutic Areas
Sponsors
Leads: Psoriasis Treatment Center of Central New Jersey